Ignite Creation Date:
2025-12-24 @ 7:07 PM
Ignite Modification Date:
2026-01-01 @ 5:14 PM
Study NCT ID:
NCT00365157
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-11
First Post:
2006-08-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-10-23
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-07-09
Completion Date Type:
ESTIMATED
First Submit Date:
2006-08-16
First Submit QC Date:
None
Study First Post Date:
2006-08-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-10
Last Update Post Date:
2025-07-11
Last Update Post Date Type:
ACTUAL